Skip to main content

Table 3 Risk factors for 30 day mortality in patients treated with BLICs

From: Comparison of therapy with β-lactam/β-lactamase inhibitor combinations or carbapenems for bacteraemia of nonurinary source caused by ESBL-producing Escherichia coli or Klebsiella pneumoniae

 

Univariate analysis

Multivariate analysis

Univariate analysis

Multivariate analysis

Variables

P

HR (95%CI), P

Adjusted P

Adjusted HR (95%CI), P

Leukemia

0.018

8.82 (1.79–43.33), 0.007

0.015

7.79 (1.48–40.86), 0.015

SOFA score

0.037

1.21 (0.98–1.50), 0.074

0.150

1.28 (0.93–1.77), 0.132

aCCI

0.033

1.22 (1.03–1.45), 0.019

0.280

 

Pitt bacteremia score

0.300

 

0.242

 

Age

0.713

 

0.959

 

Immune-compromise

0.981

 

0.659